MDX Stock Overview Develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. More details
Risk Analysis + 2 more risks
See All Risk Checks Capture your thoughts, links and company narrative
MedX Health Corp Competitors Price History & Performance
Summary of share price highs, lows and changes for MedX Health Historical stock prices Current Share Price CA$0.07 52 Week High CA$0.11 52 Week Low CA$0.025 Beta 1.35 1 Month Change 7.69% 3 Month Change 27.27% 1 Year Change 27.27% 3 Year Change 7.69% 5 Year Change -46.15% Change since IPO -76.67%
Recent News & Updates
New major risk - Financial position Dec 01
Third quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 3Q 2023) Dec 01
New major risk - Market cap size Nov 07
MedX Health Corp, Annual General Meeting, Dec 10, 2024 Oct 08
Second quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2023) Aug 30
New major risk - Market cap size Aug 07 See more updates
New major risk - Financial position Dec 01
Third quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 3Q 2023) Dec 01
New major risk - Market cap size Nov 07
MedX Health Corp, Annual General Meeting, Dec 10, 2024 Oct 08
Second quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2023) Aug 30
New major risk - Market cap size Aug 07 MedX Health Corp announced that it has received CAD 1.05 million in funding Aug 07
First quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2023) Jun 04
Full year 2023 earnings released: CA$0.023 loss per share (vs CA$0.028 loss in FY 2022) May 01 MedX Health Corp announced that it expects to receive CAD 2 million in funding May 01
New major risk - Share price stability Jan 21
Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.006 loss in 3Q 2022) Nov 30
CEO & Director exercised options to buy CA$1.3m worth of stock. Nov 20 MedX Health Corp announced that it has received CAD 1.02 million in funding Nov 15
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding Sep 01
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding Aug 31
New minor risk - Shareholder dilution Aug 27
Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2022) Aug 25
New major risk - Share price stability Jun 23
First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 1Q 2022) Jun 03 MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director
Full year 2022 earnings released: CA$0.028 loss per share (vs CA$0.03 loss in FY 2021) May 03 MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited Jan 31
Third quarter 2022 earnings released: CA$0.006 loss per share (vs CA$0.009 loss in 3Q 2021) Dec 01 MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited Nov 20
Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2021) Aug 30 MedX Health Corp announced that it expects to receive CAD 4 million in funding Jul 01
Full year 2021 earnings released: CA$0.03 loss per share (vs CA$0.019 loss in FY 2020) May 04 MedX Health Corp announced that it expects to receive CAD 4 million in funding Mar 03
Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat Dec 01
High number of new and inexperienced directors Sep 15
High number of new and inexperienced directors Sep 10
High number of new and inexperienced directors Sep 09
High number of new and inexperienced directors Sep 05
High number of new and inexperienced directors Sep 02
Chairman of the Board Robert von der Porten has left the company Aug 29
Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2020) Aug 25
COO & MD of Light Therapy Products recently sold CA$53k worth of stock Aug 13
First quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 1Q 2020) Jun 02
MedX Health Corp announced that it expects to receive CAD 2.5 million in funding May 15
Full year 2020 earnings released: CA$0.019 loss per share (vs CA$0.023 loss in FY 2019) May 01
MedX Health Corp. Announces Retirement of Board Members Mar 14
EMPOWER CLINICS INC. and MedX Health Corporation Announce Memorandum of Understanding to Pilot MedX's Leading-Edge DermSecure Screening Platform At Two Select Empower Clinics Locations in Ontario Mar 11
MedX Health Corp. Announces the Appointment of Paul Karam as Sales and Marketing Director for Europe, Middle East, Africa (EMEA) Mar 04
New 90-day high: CA$0.24 Feb 20
MedX Health Corp announced that it expects to receive CAD 4 million in funding Jan 26
MedX Health Corporation Appoints Trevor Champagne as Chair Medical Advisory Board Dec 23
Medx Health Corp. Announces the Rollout of DermSecure in the Netherlands Dec 15
Third quarter 2020 earnings released: CA$0.006 loss per share Nov 28
MedX Health Corp Announces Board Changes Oct 29
Medx Health Corp. Appoints Anthony Milonas and Wayne Cockburn as Directors Oct 16
First half earnings released Sep 27
MedX Health Corp. Announces Management Appointments Sep 22
MedX Health Corp announced that it expects to receive CAD 2 million in funding Aug 07 Shareholder Returns MDX CA Medical Equipment CA Market 7D 0% -0.8% 1.2% 1Y 27.3% -6.4% 17.2%
See full shareholder returns
Return vs Market: MDX exceeded the Canadian Market which returned 17.2% over the past year.
Price Volatility Is MDX's price volatile compared to industry and market? MDX volatility MDX Average Weekly Movement 14.0% Medical Equipment Industry Average Movement 13.6% Market Average Movement 8.3% 10% most volatile stocks in CA Market 18.6% 10% least volatile stocks in CA Market 2.9%
Stable Share Price: MDX's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: MDX's weekly volatility has decreased from 20% to 14% over the past year, but is still higher than 75% of Canadian stocks.
About the Company MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients’ mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
Show more MedX Health Corp Fundamentals Summary How do MedX Health's earnings and revenue compare to its market cap? MDX fundamental statistics Market cap CA$18.91m Earnings (TTM ) -CA$3.15m Revenue (TTM ) CA$367.99k
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) MDX income statement (TTM ) Revenue CA$367.99k Cost of Revenue CA$244.84k Gross Profit CA$123.15k Other Expenses CA$3.27m Earnings -CA$3.15m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.012 Gross Margin 33.47% Net Profit Margin -855.63% Debt/Equity Ratio -81.2%
How did MDX perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/20 11:29 End of Day Share Price 2025/01/16 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources MedX Health Corp is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Doug Cooper Beacon Securities Limited
Show 0 more analysts 
